Study on Oxymatrine-Based Research from 2001 to 2022: A Bibliometric Analysis
Xu Lan1, Yao Chen2, Jia-Jia Duan1
1Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China.
Oxymatrine, a Kushen-derived alkaloid, shows promise in organ protection, antiviral, and anticancer applications. Bibliometric analysis of 267 studies over 22 years reveals growing global research, particularly in oncology and anti-inflammatory fields.
Area of Science:
- Pharmacology
- Natural Products
- Bibliometrics
Background:
- Oxymatrine, a quinolizidine alkaloid from Kushen, exhibits diverse therapeutic properties including organ protection, anticancer, and antiviral effects.
- The broad research scope of oxymatrine necessitates a comprehensive overview of its scientific landscape.
Purpose of the Study:
- To conduct a bibliometric analysis of English-written oxymatrine research over the past 22 years.
- To summarize the current status, trends, and key research areas of oxymatrine-based studies.
Main Methods:
- Bibliometric analysis of 267 English-written studies on oxymatrine published over a 22-year period.
- Analysis of publication trends, countries of origin, research fields, and popular topics.
Main Results:
- A steady increase in annual publications with minor fluctuations was observed.
- Research on oxymatrine has expanded globally, with increasing contributions from various countries beyond China.
- Anticancer and anti-inflammatory research emerged as the most prominent fields, indicating significant therapeutic potential.
Conclusions:
- Oxymatrine research is expanding globally, highlighting its therapeutic versatility.
- Continued in-depth investigation is expected to uncover further therapeutic effects and mechanisms.
- Oxymatrine holds potential as a viable therapeutic agent for a wider range of diseases.
More Related Videos
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
